Ph.D. students get clinical training, focus on translational research

August 14, 2006

Winston-Salem, N.C. -- Five students in the Wake Forest University School of Medicine Ph.D. program in molecular medicine have recently won awards for their research. The training program is one of the first in the country to provide clinical training to doctoral students who are studying the biology of cells and molecules.

The overall objective of the program is to educate future investigators in research that translates to human disease, said Charles McCall, M.D., professor of molecular medicine. These awards attest to the program's success.

The training program is one of two molecular medicine programs in the country funded by the National Institutes of Health (NIH) to train four students a year. Of 35 students currently enrolled in the program, six have been supported by the training grant and nine have been awarded individual fellowships from the NIH or other organizations.

This program focused on translational research before the concept was developed nationally, said McCall, referring to an effort by the NIH for the nation's scientists to focus on rapidly translating knowledge from the laboratory to the bedside to benefit patients. It meets a major objective of the new Roadmap Program of the NIH.

The awards will pay for the students to complete the research phase of their training. The goal of their projects is to apply the latest knowledge of molecular medicine, the science of exploring what goes wrong at the cellular level, to better define the cause or treatment of disease.

Students are taught by both physicians and basic scientists from a variety of fields, including internal medicine, biochemistry, regenerative medicine, surgery, neuroscience, genetics, microbiology/immunology, and cancer biology.

The program includes two years of classes and three years of research with an established scientist. Before beginning the research phase of the program, students have an eight-week clinical rotation and a semester-long class in human physiology and disease. For example, a student whose laboratory research will focus on diabetes accompanies endocrinologists on hospital rounds and discusses actual cases, seeing the problems that patients face.

It is unique for doctoral students to get this type of clinical training, said Kevin High, M.D., co-director of the program. It is nearly impossible to impart the impact of one's research by reading printed materials ¨C they learn to understand the context of disease, the impact the disease has on physical, mental and social function, and the applicability of the research they are doing.

In the Molecular Basis of Human Diseases course, students examine actual case scenarios, including the symptoms presented by the patient, results of the physical examination, and diagnostic results, including x-rays and other scans, biopsy results, and laboratory tests. Group discussions focus on physiology and the molecular mechanisms of health and disease. Once the diagnosis is revealed, students learn more about treatments and how they work, how to design clinical research studies to test new therapies, and the gaps in current knowledge within the field.

The program, which began in 1998 under the direction of Floyd Ski Chilton, Ph.D., is co-directed by High, an infectious diseases specialist, and Linda McPhail, Ph.D., a biochemist.

The training program admits four to seven new students each year. Its goals include educating biomedical scientists who can move efficiently and productively between basic science and clinical settings and who can develop novel molecular approaches to treat human disease.

The recent award winners are:
Media Contacts:

Karen Richardson

Shannon Koontz
(336) 716-4587

Wake Forest University Baptist Medical Center is an academic health system comprised of North Carolina Baptist Hospital and Wake Forest University Health Sciences, which operates the university's School of Medicine. U.S. News & World Report ranks Wake Forest University School of Medicine 18th in family medicine, 20th in geriatrics, 25th in primary care and 41st in research among the nation's medical schools. It ranks 32nd in research funding by the National Institutes of Health. Almost 150 members of the medical school faculty are listed in Best Doctors in America.

Wake Forest Baptist Medical Center

Related Regenerative Medicine Articles from Brightsurf:

Stem cells: new insights for future regenerative medicine approaches
The study published in Open Biology unravels important data for a better understanding of the process of division in stem cells and for the development of safer ways to use them in medicine.

Engineered developmental signals could illuminate regenerative medicine
For a tiny embryo to develop into an adult organism, its cells must develop in precise patterns and interact with their neighbors in carefully orchestrated ways.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

New research into stem cell mutations could improve regenerative medicine
Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.

Keratin scaffolds could advance regenerative medicine and tissue engineering for humans
Researchers at Mossakowski Medical Research Center of the Polish Academy of Science have developed a simple method for preparing 3D keratin scaffold models which can be used to study the regeneration of tissue.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

A new material for regenerative medicine capable to control cell immune response
Scientists of Tomsk Polytechnic University jointly with the University of Montana (USA) proposed a new promising material for regenerative medicine for recovery of damaged tissues and blood vessels.

Optoceutics: A new technique using light for regenerative medicine
Researchers in Italy at IIT-Istituto Italiano di Tecnologia used visible light together with photo-sensitive and biocompatible materials to facilitate the formation of new blood vessels in vitro.

Major stem cell discovery to boost research into development and regenerative medicine
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells.

Spinning-prism microscope helps gather stem cells for regenerative medicine
Pluripotent stem cells are crucial to regenerative medicine, but better screening methods are needed to isolate safe and effective cells for medical use.

Read More: Regenerative Medicine News and Regenerative Medicine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to